We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agreement to Streamline Drug Development

News   Sep 22, 2005

 
Agreement to Streamline Drug Development
 
 
 

RELATED ARTICLES

Single Low-dose of Intravenous Ketamine Relieves Depressive Symptoms With Mild Side Effects

News

National Institutes of Health researchers found that a single, low-dose ketamine infusion was relatively free of side effects for patients with treatment-resistant depression.

READ MORE

ELeCt-ing a New Contender for Chemo Delivery

News

A new technique called ELeCt (erythrocyte-leveraged chemotherapy) aims to resolve the problems that come with using the age-old "Trojan Horse trick" to smuggle drug-loaded nanoparticles into cancerous lung tissue.

READ MORE

Mathematical Method Provides Deeper Understanding of Drug Interactions

News

Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences have developed a new methodology characterizing more precisely how drugs influence each other when combined during treatment.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE